Agios Pharmaceuticals
AGIO
#5167
Rank
NZ$2.75 B
Marketcap
NZ$47.26
Share price
-2.19%
Change (1 day)
-16.70%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: NZ$2.75 Billion

As of January 2026 Agios Pharmaceuticals has a market cap of NZ$2.75 Billion. This makes Agios Pharmaceuticals the world's 5167th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.75 B-2.31%
2025NZ$2.82 B-16.47%
2024NZ$3.37 B71.6%
2023NZ$1.96 B-19.01%
2022NZ$2.43 B-7.02%
2021NZ$2.61 B-37.16%
2020NZ$4.15 B-14.24%
2019NZ$4.84 B21.18%
2018NZ$4.00 B1.97%
2017NZ$3.92 B55.06%
2016NZ$2.53 B-29.21%
2015NZ$3.57 B-32.6%
2014NZ$5.30 B483.39%
2013NZ$0.90 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

NZ$2.75 Billion
by Nasdaq info icon info icon
NZ$2.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$1.58 B-42.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$20.57 B 646.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.49 B 9,097.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$18.22 B 561.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.39 B 6,046.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
NZ$1.618 T 58,610.18%๐Ÿ‡บ๐Ÿ‡ธ USA